CLEARSIDE BIOMEDICAL INC

CLSDQ

0.24900.00% ( 0.0000 )

Delay Closed: Nov 13, 16:00:00 (EDT)

Current ValuationThe current P/E ratio is -0.05, within the reasonable range, cheaper than 42.8% of the time in the past 1 years, and the industry ranks 64/257, the industry Median -0.95.

-0.0501xP/E

Stock price$0.25Earnings per share$-4.97

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

03876114152

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x20x40x60x80x100x

P/E ratio
Name/Symbol
BAYRYUSBayer	-37.02x	--	$61.54B
BAYZFUSBayer Aktiengesellschaft	-36.93x	--	$61.38B
VTRSUSViatris	-39.27x	97.55%	$23.87B
ELANUSElanco Animal Health	-91.06x	168.15%	$13.39B
ABVXUSAbivax SA	-16.42x	22.99%	$7.63B
AXSMUSAxsome Therap	-47.38x	29.75%	$7.45B
BLTEUSBelite Bio	-64.66x	28.79%	$6.62B
CURLFUSCuraleaf Holdings, Inc.	-291.14x	--	$6.01B
VREOFUSVIREO GROWTH INC	-88.41x	--	$5.82B
MANEUSVeraDermics	-52.74x	97.55%	$5.42B
LQDAUSLiquidia Tech	-54.92x	69.38%	$5.17B
DFTXUSDefinium Therapeutics	-13.01x	41.75%	$4.39B
TARSUSTarsus Pharmaceuticals	-5.64x	879.07%	$3.96B
AMLXUSAmylyx Pharmaceuticals	-23.86x	0.72%	$3.89B
ELVNUSEnliven Therapeutics	-31.65x	3.43%	$3.59B
BHCUSBausch Health	-3.72x	511.90%	$3.13B
XERSUSXeris Biopharma	-468.56x	--	$3.04B
MBXUSMBX Biosciences	-18.57x	50.08%	$2.69B
RGCUSRegencell Bioscience	-209.17x	--	$2.45B
PHVSUSPharvaris BV	-11.82x	16.90%	$2.34B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.